See also this year's filing and all EDGAR filings for this company.
PDF Report 0001367644_2023_Emergent_BioSolutions_Inc.pdf
Logs
warning | Large missing amount for aggregate "Revenues" added to remainder. | industry.us_generic | {'missing_ratio': 227.75510204081633, 'aggregate_val': 1120900000, 'exp_sum': 4900000, 'exp_to_value': {'remainder_Revenues': 4900000}} |
info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001367644, Emergent BioSolutions Inc.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 1,210,700,000 |
1 | IntangibleAssetsNetIncludingGoodwill | 947,000,000 |
2 | PropertyPlantAndEquipmentNet | 817,600,000 |
3 | remainder_Assets | 191,300,000 |
4 | LiabilitiesCurrent | 1,229,900,000 |
5 | LiabilitiesNoncurrent | 481,900,000 |
6 | remainder_Liabilities | 71,800,000 |
7 | CostOfGoodsAndServicesSold | 693,700,000 |
8 | SellingGeneralAndAdministrativeExpense | 340,300,000 |
9 | ResearchAndDevelopmentExpense | 193,000,000 |
10 | remainder_Expenses | 68,700,000 |
11 | remainder_Revenues | 1,120,900,000 |
12 | remainder_NetIncome | -49,000,000 |
13 | remainder_ComprehensiveNetIncome | 19,200,000 |
yvar | yval | |
---|---|---|
0 | Assets | 3,166,600,000 |
1 | Liabilities | 1,783,600,000 |
2 | Expenses | 1,295,700,000 |
3 | Revenues | 1,120,900,000 |
4 | StockholdersEquity | 1,383,000,000 |
5 | NetIncome | -223,800,000 |
6 | ComprehensiveNetIncome | -214,200,000 |
7 | BaseVar | 3,717,500,000 |
8 | EconomicCapitalRatio | 0.875 |